{
    "clinical_study": {
        "@rank": "92447", 
        "arm_group": [
            {
                "arm_group_label": "Accelerated treatment", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Standard treatment", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether accelerated treatment with custom-made\n      compression sleeve is more effective than standard procedure in the treatment of mild and\n      moderate arm lymphedema secondary to primary cancer treatment."
        }, 
        "brief_title": "Effectiveness of Accelerated Intervention With Compression Sleeve in Mild and Moderate Breast Cancer-related Lymphedema", 
        "condition": [
            "Breast Cancer", 
            "Lymphedema"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Lymphedema"
            ]
        }, 
        "detailed_description": {
            "textblock": "Use of a custom-made compression sleeve is an initial treatment of mild and moderate arm\n      lymphedema secondary to primary breast cancer treatment. The compression sleeve improves the\n      flow of lymph fluid out of the arm, reduces the swelling, and prevents progression of the\n      lymphedema in the future.\n\n      Early intervention is recommended though early is not well-defined in literature. The\n      purpose of this study is to evaluate reduction of excess limb volume and changes in arm\n      disability and clinical symptoms in accelerated treatment with compression sleeve compared\n      to standard treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participants must be refered for the first time due to unilateral arm lymphedema\n             secondary to primary unilateral breast cancer treatment\n\n          -  Participants must be \u2265 2 months after chemo- and radiotherapy\n\n          -  Participants must have ELV \u226510% and < 30% and/or > 2 cm difference between the\n             circumference of the two arms at minimum one circumference due to lymphedema\n\n          -  Participants must be motivated for treatment with compression sleeve and -gauntlet\n\n          -  Participants live in and around Aarhus, Denmark\n\n        Exclusion Criteria:\n\n          -  Known metastatic disease\n\n          -  Contraindication for treatment with compression sleeve\n\n          -  Upper extremity deep venous thrombosis\n\n          -  Previously use of compression sleeve\n\n          -  Known contact allergy to latex\n\n          -  Unable to fill in questionnaire and/or comply with treatment due to lacking Danish\n             language skills, mental state or psychological condition"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "95 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01954654", 
            "org_study_id": "2007-58-0010"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Accelerated treatment", 
                    "Standard treatment"
                ], 
                "description": "Device: Compression garments worn for a minimum of six hours per day", 
                "intervention_name": "Custom-made compression sleeve and -gauntlet", 
                "intervention_type": "Device", 
                "other_name": "Jobst Elvarex"
            }, 
            {
                "arm_group_label": [
                    "Accelerated treatment", 
                    "Standard treatment"
                ], 
                "description": "Educational information and recommendations about lymphedema and skin care. Instruction in physical exercises to enhance the lymph flow", 
                "intervention_name": "Educational information, recommendation and instruction", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 6, 2013", 
        "location": {
            "contact": {
                "email": "Mette.Brodersen.jerver@auh.rm.dk", 
                "last_name": "Mette B Jerver", 
                "phone": "+45 78 46 22 10"
            }, 
            "facility": {
                "address": {
                    "city": "Aarhus", 
                    "country": "Denmark", 
                    "zip": "8000"
                }, 
                "name": "Aarhus University Hospital, Fysioterapi- og Ergoterapisfdelingen"
            }, 
            "investigator": {
                "last_name": "Mette B Jerver", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effectiveness of Accelerated Intervention With Custom-made Compression Sleeve in Women With Mild and Moderate Arm Lymphedema Secondary to Breast Cancer Treatment", 
        "overall_contact": {
            "email": "Mette.Brodersen.Jerver@auh.rm.dk", 
            "last_name": "Mette B Jerver", 
            "phone": "+45 78 46 22 10"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Dataprotection Agency"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "ELV in the affected arm compared to the non-affected arm. ELV described as both absolute volume in ml and relative volume in percent", 
            "measure": "Change of excess limb volume (ELV)", 
            "safety_issue": "No", 
            "time_frame": "8 weeks follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01954654"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Aarhus University Hospital", 
            "investigator_full_name": "Mette Brodersen Jerver", 
            "investigator_title": "Physiotherapist", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Measured with Disabilities of Arm, Shoulder, and Hand (DASH)", 
                "measure": "Changes in arm disability", 
                "safety_issue": "No", 
                "time_frame": "8 weeks follow-up"
            }, 
            {
                "measure": "Changes in subjective symptoms (pain, tension, and heaviness)", 
                "safety_issue": "No", 
                "time_frame": "8 weeks follow-up"
            }
        ], 
        "source": "Aarhus University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mette Brodersen Jerver", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}